BRIEF published on 05/20/2026 at 17:50, 20 days 7 hours ago Mauna Kea Technologies is expanding into the Middle East Mauna Kea Technologies CellTolerance Middle East Expansion Regulatory Authorizations Irritable Bowel Syndrome
BRIEF published on 05/18/2026 at 17:50, 22 days 7 hours ago Mauna Kea Technologies Proposes New Board Members Annual General Meeting Shareholder Voting Strategic Transformation Board Nominations Mauna Kea Technologies
PRESS RELEASE published on 05/18/2026 at 17:45, 22 days 7 hours ago Inside Information / Other news releases Mauna Kea Technologies nominates 3 new directors to accelerate strategic transformation in 2025. Shareholder approval awaited for upcoming Annual General Meeting Annual General Meeting Shareholder Approval New Directors Strategic Transformation Mauna Kea Technologies
BRIEF published on 04/15/2026 at 17:50, 1 month 24 days ago Mauna Kea Technologies to experience strong growth in Q1 2026 Revenue Growth Medical Technologies Cellvizio Food Intolerances
BRIEF published on 03/11/2026 at 17:50, 2 months 29 days ago Mauna Kea Technologies Achieves Milestone with CLIMB Study Mauna Kea Technologies Cellvizio Pancreatic Cysts CLIMB Study ASGE Plenary Session
PRESS RELEASE published on 03/11/2026 at 17:45, 2 months 29 days ago Inside Information / Other news releases Mauna Kea Technologies announces CLIMB study for Cellvizio® in Pancreatic Cysts selected for ASGE Presidential Plenary Session at DDW 2026, showcasing superior diagnostic accuracy and clinical impact Mauna Kea Technologies Cellvizio Pancreatic Cysts CLIMB Study ASGE
BRIEF published on 02/10/2026 at 17:50, 3 months 27 days ago Mauna Kea Technologies Secures CE MDR Certification for Cellvizio® Cellvizio Clinical Expansion CE MDR Certification European Commercialization MedTech Regulation
PRESS RELEASE published on 02/10/2026 at 17:45, 3 months 27 days ago Inside Information / Other news releases Mauna Kea Technologies announces CE MDR certification for Cellvizio and probes, marking a key milestone in their European expansion strategy under new regulation Mauna Kea Technologies Cellvizio Regulatory Milestone CE MDR Certification European Expansion Strategy
BRIEF published on 01/21/2026 at 17:50, 4 months 19 days ago Mauna Kea Technologies: 2026 Financial Calendar Unveiled Investor Conferences Financial Calendar Growth Strategies Mauna Kea Technologies Cellvizio
BRIEF published on 11/20/2025 at 17:50, 6 months 19 days ago Mauna Kea's Cellvizio Gen 3 receives approval in China NMPA Approval Chinese Market Mauna Kea Cellvizio Gen 3 Endoscopy
Published on 06/10/2026 at 00:00, 1 hour 41 minutes ago Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
Published on 06/09/2026 at 23:00, 2 hours 41 minutes ago NXT Energy Solutions Inc. Announces Results of Annual Meeting of Shareholders
Published on 06/09/2026 at 22:30, 3 hours 11 minutes ago Gamma Resources Announces Receipt of $604,500 from Warrant Exercises
Published on 06/09/2026 at 21:45, 3 hours 56 minutes ago Northfield Announces Change of Corporate Name to Juno International Corporation
Published on 06/09/2026 at 15:00, 10 hours 41 minutes ago Worksport Ltd. Reports Additional $50,000 CEO Insider Stock Acquisition, Reinforcing Confidence in Long-Term Value Creation
Published on 06/09/2026 at 22:55, 2 hours 46 minutes ago JACOBS STEPS-UP AS 'OFFICIAL SPONSOR OF STAYING AWAKE' AS SCHEDULE REVEALS SUMMER MATCH TIMES WILL PUSH EUROPEAN FOOTBALL FANS TO THE LIMIT
Published on 06/09/2026 at 22:35, 3 hours 6 minutes ago Eurobattery Minerals publishes Annual Report 2025
Published on 06/09/2026 at 19:32, 6 hours 8 minutes ago 2CRSi SA: 2CRSi announces a €110 million sale of Godì Blackwell Ultra servers in Germany
Published on 06/09/2026 at 19:10, 6 hours 30 minutes ago The 2026 Global Energy Prize shortlist released
Published on 06/09/2026 at 19:10, 6 hours 30 minutes ago THE SULTANATE OF OMAN CONSOLIDATES ITS POSITION AS A STABLE DESTINATION FOR GLOBAL CAPITAL
Published on 06/09/2026 at 19:30, 6 hours 11 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 06/09/2026 at 18:14, 7 hours 27 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/05/2026
Published on 06/09/2026 at 15:17, 10 hours 23 minutes ago Statement of transactions in own shares from June 1, 2026 to June 5, 2026
Published on 06/09/2026 at 10:37, 15 hours 4 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from June 1 to June 5 2026
Published on 06/09/2026 at 07:00, 18 hours 41 minutes ago New strategic Milestone for Biophytis: Official Establishment of Its Joint Venture in Asia
